Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Zeitschrift Fur Rheumatologie
|
October 27, 2019
[Osteoporosis: long-term treatment versus drug holiday-what is the evidence?]
P Farahmand, J Cassens
Rheumatology International
|
January 22, 2013
Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile
J D Ringe, P Farahmand
Rheumatology International
|
April 25, 2012
Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients
J D Ringe, P Farahmand, E Schacht
Zeitschrift Fur Rheumatologie
|
April 28, 2016
[Male osteoporosis]
P Farahmand, R Spiegel, J D Ringe
Rheumatology International
|
July 8, 2005
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
J D Ringe, H Faber, P Farahmand, et al.
Rheumatology International
|
January 12, 2007
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
J D Ringe, P Farahmand, E Schacht, et al.
Physiotherapy
|
March 23, 2015
Validity of linear encoder measurement of sit-to-stand performance power in older people
U Lindemann, P Farahmand, J Klenk, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
February 16, 2008
Is hypogastric artery embolization during endovascular aortoiliac aneurysm repair (EVAR) innocuous and useful?
P Farahmand, J P Becquemin, P Desgranges, et al.
Journal of Cellular Physiology
|
August 12, 1998
Evidence for integrin receptor involvement in megakaryocyte-fibroblast interaction: a possible pathomechanism for the evolution of myelofibrosis
B Schmitz, J Thiele, F Otto, et al.
Leukemia Research
|
November 15, 2000
Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow
C Wickenhauser, B Schmitz, S E Baldus, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Zeitschrift Fur Rheumatologie
|
October 27, 2019
[Osteoporosis: long-term treatment versus drug holiday-what is the evidence?]
P Farahmand, J Cassens
Rheumatology International
|
January 22, 2013
Improved real-life adherence of 6-monthly denosumab injections due to positive feedback based on rapid 6-month BMD increase and good safety profile
J D Ringe, P Farahmand
Rheumatology International
|
April 25, 2012
Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients
J D Ringe, P Farahmand, E Schacht
Zeitschrift Fur Rheumatologie
|
April 28, 2016
[Male osteoporosis]
P Farahmand, R Spiegel, J D Ringe
Rheumatology International
|
July 8, 2005
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
J D Ringe, H Faber, P Farahmand, et al.
Rheumatology International
|
January 12, 2007
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
J D Ringe, P Farahmand, E Schacht, et al.
Physiotherapy
|
March 23, 2015
Validity of linear encoder measurement of sit-to-stand performance power in older people
U Lindemann, P Farahmand, J Klenk, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
February 16, 2008
Is hypogastric artery embolization during endovascular aortoiliac aneurysm repair (EVAR) innocuous and useful?
P Farahmand, J P Becquemin, P Desgranges, et al.
Journal of Cellular Physiology
|
August 12, 1998
Evidence for integrin receptor involvement in megakaryocyte-fibroblast interaction: a possible pathomechanism for the evolution of myelofibrosis
B Schmitz, J Thiele, F Otto, et al.
Leukemia Research
|
November 15, 2000
Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow
C Wickenhauser, B Schmitz, S E Baldus, et al.
Page
of 2